SpringWorks Therapeutics, Inc. (SWTX)
Jul 1, 2025 - SWTX was delisted (reason: acquired by Merck KGaA)
46.99
0.00 (0.00%)
Inactive · Last trade price
on Jun 30, 2025
SpringWorks Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 63.77 | 69.75 | 176.05 | 67.49 | 103.96 | 147.09 | Upgrade
|
Short-Term Investments | 224.1 | 238.23 | 303.15 | 524.72 | 269.54 | 361.4 | Upgrade
|
Cash & Short-Term Investments | 287.87 | 307.99 | 479.2 | 592.21 | 373.5 | 508.48 | Upgrade
|
Cash Growth | -34.06% | -35.73% | -19.08% | 58.56% | -26.55% | 55.19% | Upgrade
|
Receivables | 40.35 | 46.24 | 5.93 | - | - | - | Upgrade
|
Inventory | 12.42 | 10.21 | 3.1 | - | - | - | Upgrade
|
Prepaid Expenses | 15.68 | 16.03 | 12.68 | 7.55 | 9.41 | 4.91 | Upgrade
|
Total Current Assets | 356.32 | 380.47 | 500.91 | 599.76 | 382.91 | 513.4 | Upgrade
|
Property, Plant & Equipment | 25.83 | 26.66 | 24.09 | 18.27 | 4.2 | 3.02 | Upgrade
|
Long-Term Investments | 94.78 | 158.12 | 185.34 | 8.99 | 62.11 | 57.21 | Upgrade
|
Other Intangible Assets | - | 15.56 | 11.2 | - | - | - | Upgrade
|
Other Long-Term Assets | 28.43 | 6.47 | 4.25 | 3.23 | 3.27 | 2.57 | Upgrade
|
Total Assets | 505.36 | 587.28 | 725.79 | 630.24 | 452.49 | 576.19 | Upgrade
|
Accounts Payable | 14.93 | 12.25 | 7.4 | 8.01 | 3.43 | 1.35 | Upgrade
|
Accrued Expenses | 65.64 | 86.01 | 65.57 | 39.24 | 25.38 | 14.89 | Upgrade
|
Current Portion of Leases | 1.7 | 1.73 | 1.06 | 0.48 | 1.16 | 1.38 | Upgrade
|
Current Unearned Revenue | - | - | 4.14 | 3.31 | - | - | Upgrade
|
Total Current Liabilities | 82.27 | 99.99 | 78.17 | 51.05 | 29.97 | 17.61 | Upgrade
|
Long-Term Leases | 5.69 | 6.18 | 6 | 4.77 | 0.13 | 1.36 | Upgrade
|
Long-Term Unearned Revenue | - | - | 15.4 | 16.23 | - | - | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | - | 0.16 | Upgrade
|
Total Liabilities | 87.96 | 106.17 | 99.57 | 72.05 | 30.1 | 19.13 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 1,679 | 1,647 | 1,524 | 1,130 | 715.22 | 675.62 | Upgrade
|
Retained Earnings | -1,236 | -1,153 | -895.03 | -569.93 | -292.51 | -118.6 | Upgrade
|
Treasury Stock | -25.45 | -12.58 | -4.14 | -1.34 | - | - | Upgrade
|
Comprehensive Income & Other | 0.44 | 0.3 | 1.19 | -0.77 | -0.31 | 0.04 | Upgrade
|
Total Common Equity | 417.4 | 481.1 | 626.22 | 558.19 | 422.4 | 557.06 | Upgrade
|
Shareholders' Equity | 417.4 | 481.1 | 626.22 | 558.19 | 422.4 | 557.06 | Upgrade
|
Total Liabilities & Equity | 505.36 | 587.28 | 725.79 | 630.24 | 452.49 | 576.19 | Upgrade
|
Total Debt | 7.39 | 7.91 | 7.06 | 5.25 | 1.29 | 2.73 | Upgrade
|
Net Cash (Debt) | 375.26 | 454.01 | 655.53 | 591.76 | 431.44 | 559.09 | Upgrade
|
Net Cash Growth | -33.75% | -30.74% | 10.78% | 37.16% | -22.83% | 70.63% | Upgrade
|
Net Cash Per Share | 5.04 | 6.12 | 10.38 | 11.10 | 8.90 | 12.91 | Upgrade
|
Filing Date Shares Outstanding | 75.32 | 74.92 | 73.68 | 62.28 | 48.87 | 48.29 | Upgrade
|
Total Common Shares Outstanding | 74.99 | 74.39 | 73.38 | 62.2 | 48.78 | 48.13 | Upgrade
|
Working Capital | 274.05 | 280.48 | 422.74 | 548.71 | 352.94 | 495.79 | Upgrade
|
Book Value Per Share | 5.57 | 6.47 | 8.53 | 8.97 | 8.66 | 11.57 | Upgrade
|
Tangible Book Value | 417.4 | 465.55 | 615.02 | 558.19 | 422.4 | 557.06 | Upgrade
|
Tangible Book Value Per Share | 5.57 | 6.26 | 8.38 | 8.97 | 8.66 | 11.57 | Upgrade
|
Machinery | - | 5.93 | 3.26 | 0.81 | 0.52 | 0.25 | Upgrade
|
Construction In Progress | - | 1.79 | 3.57 | 7.14 | 1.97 | 0.1 | Upgrade
|
Leasehold Improvements | - | 3.03 | 0.83 | 0.83 | 1.36 | 1.18 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.